Page last updated: 2024-08-24

1,2-dipalmitoyl-3-phosphatidylethanolamine and pyrilamine

1,2-dipalmitoyl-3-phosphatidylethanolamine has been researched along with pyrilamine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bogdanovic, RP; Brandes, LJ1
Brandes, LJ; Kroeger, EA1

Other Studies

2 other study(ies) available for 1,2-dipalmitoyl-3-phosphatidylethanolamine and pyrilamine

ArticleYear
New evidence that the antiestrogen binding site may be a novel growth-promoting histamine receptor (?H3) which mediates the antiestrogenic and antiproliferative effects of tamoxifen.
    Biochemical and biophysical research communications, 1986, Jan-29, Volume: 134, Issue:2

    Topics: Animals; Binding, Competitive; Biological Assay; Cimetidine; Female; Hydroxyzine; Microsomes, Liver; Ovariectomy; Phosphatidylethanolamines; Pyrilamine; Rats; Receptors, Estrogen; Receptors, Histamine; Structure-Activity Relationship; Tamoxifen; Uterus

1986
Evidence that tamoxifen is a histamine antagonist.
    Biochemical and biophysical research communications, 1985, Sep-16, Volume: 131, Issue:2

    Topics: Acetylcholine; Animals; Dogs; Female; Histamine; Histamine Antagonists; Hydroxyzine; Male; Muscle Contraction; Phosphatidylethanolamines; Potassium; Pyrilamine; Serotonin; Tamoxifen; Trachea

1985